DPSCs were cultured under osteogenic medium containing α-MEM supplemented with 15% FBS, 100 mM L-ascorbic acid-2-phosphate, 2 mM Lglutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin, 1.8 mM KH 2 PO4 and 10 nM dexamethasone (Sigma-Aldrich). After 28 days of induction, the cultures were stained with Alizarin Red. Expression of the osteogenic/odontoblastic marker ALP, RUNX2 and DSPP was assayed by qPCR analysis. The primers used for qPCR analysis were listed in supplementary table.
glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin, 0.5 mM Isobutylmethylxanthin (Sigma-Aldrich), 60 µM Indomethacin (Sigma-Aldrich), 0.5 µM Hydrocortisone (Sigma-Aldrich), and 10 µg/ml Insulin (Sigma-Aldrich). After 14 days of adipogenic induction, the cultures were stained with Oil Red O.
Expression of the adipogenic lineage-specific genes LPL and PPARγ was assayed by qPCR. The primers used for qPCR analysis were listed in supplementary table.
Immunofluorescent staining.
DPSCs were seeded on a 4-well chamber slide and incubated for 12 hours under 37 °C at 5% CO 2 condition. Then the slides were fixed in 4% paraformaldehyde, followed by 0.01% Triton-100 treatment for 10 min. The slides were blocked with normal serum matched to secondary antibodies for 1 hour, followed by incubation with the specific or isotype-matched antibodies (1:100) overnight at 
Immunohistochemical staining
Dental pulp tissue sections from WT and Cbs -/-mice were used.
Immunohistochemistry was performed with a two-step detection kit (Zhongshan Golden Bridge Biotechnology, China) as manufacturer's instruction. Primary antibodies against rat β-catenin (1:100), active-β-catenin (1:100), p-AKT(1:100), p-GSK3β (1:100) and CBS (1:200) were used. Positive and total cell numbers were counted in 5 images per subject. The positive cells (%) were indicated as a percentage of immunohistochemistry positive cells and the total cell number.
Western blot.
Cells were lysed in M-PER® mammalian protein extraction reagent (Pierce).
Twenty µg total proteins were applied and separated on 4-12% NuPAGE® gel (Invitrogen) and transferred on Immobilon™-P membranes (Millipore Corporation). The membranes were blocked with 5% non-fat dry milk and 0.1%
Tween 20 for 1 h, followed by incubation with the primary antibodies (1:100-1000 dilution) at 4 o C overnight. Then they were treated with horseradish peroxidaseconjugated rabbit or mouse IgG (Santa Cruz) (1:10,000) for 1 h, enhanced with a SuperSignal® West Pico Chemiluminescent Substrate (Pierce, Rockford, IL), and exposed on BIOMAX MR films (Kodak, Rochester, NY).
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